Compare SNX & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNX | BAX |
|---|---|---|
| Founded | 1980 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7B | 10.2B |
| IPO Year | 2003 | 1994 |
| Metric | SNX | BAX |
|---|---|---|
| Price | $157.97 | $18.06 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 9 |
| Target Price | ★ $168.60 | $22.38 |
| AVG Volume (30 Days) | 464.5K | ★ 9.2M |
| Earning Date | 04-10-2026 | 05-14-2026 |
| Dividend Yield | ★ 1.23% | 0.23% |
| EPS Growth | ★ 25.16 | N/A |
| EPS | ★ 9.95 | N/A |
| Revenue | ★ $20,053,764,000.00 | $11,244,000,000.00 |
| Revenue This Year | $5.01 | $1.90 |
| Revenue Next Year | $4.18 | $2.09 |
| P/E Ratio | $15.66 | ★ N/A |
| Revenue Growth | ★ 17.65 | 5.72 |
| 52 Week Low | $92.23 | $17.07 |
| 52 Week High | $175.56 | $35.03 |
| Indicator | SNX | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 48.28 | 37.46 |
| Support Level | $144.64 | $17.69 |
| Resistance Level | $159.01 | $19.31 |
| Average True Range (ATR) | 4.44 | 0.71 |
| MACD | -0.49 | -0.34 |
| Stochastic Oscillator | 46.19 | 19.91 |
TD Synnex Corp is a distributor and solutions aggregator for the IT ecosystem. The company aggregates and distributes IT hardware, software, and systems including personal computing devices and peripherals, mobile phones and accessories, printers, server and data center infrastructure, hybrid cloud, security, networking, communications and storage solutions, and system components. Its geographical segments include the Americas, Europe, and APJ.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.